{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T16:00:16Z","timestamp":1761408016851,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"vor","delay-in-days":38,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006416","name":"Universidade Estadual de Campinas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bjid.2021.101544","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T12:07:12Z","timestamp":1613390832000},"page":"101544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical outcomes and molecular characterization of drug-resistant tuberculosis in pre- and extensively drug-resistant disease based on line probe assays"],"prefix":"10.1016","volume":"25","author":[{"given":"Lauane G.","family":"Ara\u00fajo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcia T.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00e2nia R.","family":"Zaccariotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luiza","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos E.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7923-0076","authenticated-orcid":false,"given":"Mari\u00e2ngela R.","family":"Resende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2015","series-title":"The end TB strategy","author":"World Health Organization","key":"10.1016\/j.bjid.2021.101544_bib0120"},{"year":"2018","series-title":"Global tuberculosis report","author":"World Health Organization","key":"10.1016\/j.bjid.2021.101544_bib0125"},{"key":"10.1016\/j.bjid.2021.101544_bib0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coph.2018.05.013","article-title":"Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment","volume":"4","author":"Koch","year":"2018","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.bjid.2021.101544_bib0135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tube.2015.11.005","article-title":"Systematic review: comparison of Xpert MTB\/RIF, LAMP and SAT methods for the diagnosis of pulmonary tuberculosis","volume":"96","author":"Yan","year":"2016","journal-title":"Tuberculosis"},{"key":"10.1016\/j.bjid.2021.101544_bib0140","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.cmi.2017.11.015","article-title":"Prevalence, associated factors, outcomes and transmission of extensively drug-resistance tuberculosis patients in S\u00e3o Paulo, Brazil: a cross-sectional study","volume":"24","author":"Gallo","year":"2017","journal-title":"Clin Microbiol Infect"},{"year":"2019","series-title":"Global tuberculosis report","author":"World Health Organization","key":"10.1016\/j.bjid.2021.101544_bib0145"},{"year":"2011","series-title":"Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Vigil\u00e2ncia Epidemiol\u00f3gica. Manual de recomenda\u00e7\u00f5es para o controle da tuberculose no Brasil","author":"Minist\u00e9rio da Sa\u00fade","key":"10.1016\/j.bjid.2021.101544_bib0150"},{"year":"2019","series-title":"Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Vigil\u00e2ncia das Doen\u00e7as Transmiss\u00edveis. Manual de recomenda\u00e7\u00f5es para o controle da tuberculose no Brasil","author":"Minist\u00e9rio da Sa\u00fade","key":"10.1016\/j.bjid.2021.101544_bib0155"},{"year":"2016","series-title":"The use of molecular line probe assays for detection of resistance to isoniazid and rifampicin","author":"World Health Organization","key":"10.1016\/j.bjid.2021.101544_bib0160"},{"year":"2016","series-title":"The use of molecular line probe assays for detection of resistance to second-line tuberculosis drugs","author":"World Health Organization","key":"10.1016\/j.bjid.2021.101544_bib0165"},{"year":"2018","series-title":"Algorithms for the diagnosis of tuberculosis. Strengthening of the network of tuberculosis laboratories in the region of the Americas","author":"Pan American Health Organization","key":"10.1016\/j.bjid.2021.101544_bib0170"},{"key":"10.1016\/j.bjid.2021.101544_bib0175","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijtb.2016.07.009","article-title":"Rapid detection of extensively drug- resistant (XDR-TB) strains from multidrug-resistant tuberculosis (MDR-TB) cases isolated from smear-negative pulmonary samples in an intermediate reference laboratory in India","volume":"63","author":"Vashistha","year":"2016","journal-title":"Indian J Tuberc"},{"key":"10.1016\/j.bjid.2021.101544_bib0180","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jac\/dkr566","article-title":"A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system","volume":"67","author":"Maruri","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2021.101544_bib0185","first-page":"136","article-title":"Characterization of gyrA and gyrB mutations and fluoroquinolones resistance in Mycobacterium tuberculosis clinical isolates from Hubei Province, China","volume":"6","author":"Chen","year":"2012","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.bjid.2021.101544_bib0190","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010705.pub3","article-title":"GenoType\u00ae MTBDRsl assay for resistance to second-line anti-tuberculosis drugs","author":"Theron","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"year":"2008","series-title":"Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Vigil\u00e2ncia Epidemiol\u00f3gica. Manual nacional de vigil\u00e2ncia laboratorial da tuberculose e outras micobacterioses","author":"Minist\u00e9rio da Sa\u00fade","key":"10.1016\/j.bjid.2021.101544_bib0195"},{"key":"10.1016\/j.bjid.2021.101544_bib0200","first-page":"818","article-title":"Differentiation of Mycobacterium complex by PCR amplification of genomic regions of difference","volume":"10","author":"Warren","year":"2006","journal-title":"Int J Lung Dis"},{"year":"2016","series-title":"Global tuberculosis report","author":"World Health Organization","key":"10.1016\/j.bjid.2021.101544_bib0205"},{"key":"10.1016\/j.bjid.2021.101544_bib0210","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4322\/2357-9730.81891","article-title":"Global epidemiology of patients with multi-drug resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB)","volume":"38","author":"Del Arco","year":"2018","journal-title":"Clin Biomed Res"},{"key":"10.1016\/j.bjid.2021.101544_bib0215","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jinf.2018.06.014","article-title":"Multi-center evaluation of GenoType MTBDRsl line probe assay for rapid detection of pre-XDR and XDR Mycobacterium tuberculosis in China","volume":"77","author":"Gao","year":"2018","journal-title":"J Infect"},{"key":"10.1016\/j.bjid.2021.101544_bib0220","doi-asserted-by":"crossref","first-page":"e01550","DOI":"10.1128\/AAC.01550-17","article-title":"What is resistance? Impact of phenotypic versus molecular drug resistance testing on therapy for multi- and extensively drug-resistant tuberculosis","volume":"62","author":"Heyckendorf","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2021.101544_bib0225","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijantimicag.2013.04.027","article-title":"Fluoroquinolone susceptibility in Mycobacterium tuberculosis after pre-diagnosis exposure to older- versus newer-generation fluoroquinolones","volume":"42","author":"Van der Heijden","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bjid.2021.101544_bib0230","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1128\/AAC.00539-16","article-title":"Role of gyrB mutations in pre-extensively and extensively drug-resistant tuberculosis in Thai clinical isolates","volume":"60","author":"Disratthakit","year":"2016","journal-title":"Antimicrob Agents Chemother"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867021000076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867021000076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:56:05Z","timestamp":1761407765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867021000076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1413867021000076"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2021.101544","relation":{},"ISSN":["1413-8670"],"issn-type":[{"type":"print","value":"1413-8670"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes and molecular characterization of drug-resistant tuberculosis in pre- and extensively drug-resistant disease based on line probe assays","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2021.101544","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedade Brasileira de Infectologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101544"}}